Real-Life Effectiveness of iGlarLixi (Insulin Glargine 100 U/ml and Lixisenatide) in People with Type 2 Diabetes (T2D) according to Baseline BMI

被引：0
|
作者：
Kis, Janos T.
Seufert, Jochen
Haluzik, Martin
Vera, Carine
Tournay, Mathilde
Bonnemaire, Mireille
Freemantle, Nick
Guja, Cristian
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-786-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
786-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-Life Effectiveness of iGlarLixi (Insulin Glargine 100 U/ml and Lixisenatide) in People with Type 2 Diabetes (T2D) According to Baseline HbA1c and BMI
    Kis, Janos T.
    Seufert, Jochen
    Haluzik, Martin
    Bonnemaire, Mireille
    Vera, Carine
    Tournay, Mathilde
    Freemantle, Nick
    Guja, Cristian
    [J]. DIABETES THERAPY, 2024, 15 (11) : 2337 - 2350
  • [2] Real-Life Effectiveness of iGlarLixi (Insulin Glargine 100 U/ml and Lixisenatide) in People with Type 2 Diabetes (T2D) according to Prior Insulin Use
    Seufert, Jochen
    Freemantle, Nick
    Guja, Cristian
    Haluzik, Martin
    Bigot, Gregory
    Tournay, Mathilde
    Bonnemaire, Mireille
    Kis, Janos T.
    [J]. DIABETES, 2023, 72
  • [3] Real-life effectiveness of iGlarLixi (insulin glargine 100 U/mL and lixisenatide) in people with type 2 diabetes according to prior insulin use
    Seufert, Jochen
    Freemantle, Nick
    Guja, Cristian
    Haluzik, Martin
    Tournay, Mathilde
    Vera, Carine
    Bonnemaire, Mireille
    Kis, Janos T.
    [J]. DIABETES OBESITY & METABOLISM, 2024, 26 (07): : 2988 - 2992
  • [4] Effectiveness of IGlarLixi, a Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide, in People with Type 2 Diabetes
    Kis, Janos Tibor
    Nagy, Gabor
    Kovacs, Gabor
    [J]. DIABETES THERAPY, 2021, 12 (09) : 2517 - 2529
  • [5] Effectiveness of IGlarLixi, a Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide, in People with Type 2 Diabetes
    János Tibor Kis
    Gábor Nagy
    Gábor Kovacs
    [J]. Diabetes Therapy, 2021, 12 : 2517 - 2529
  • [6] iGlarLixi: A Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide for the Treatment of Type 2 Diabetes
    Goldman, Jennifer
    Trujillo, Jennifer M.
    [J]. ANNALS OF PHARMACOTHERAPY, 2017, 51 (11) : 990 - 999
  • [7] Effectiveness of iGlarLixi (Insulin Glargine-Lixisenatide) in People with Type 2 Diabetes According to the Time of Administration through the Day
    Haluzik, Martin
    Seufert, Jochen
    Guja, Cristian
    Bonnemaire, Mireille
    Bigot, Gregory
    Tournay, Mathilde
    Kis, Janos T.
    Freemantle, Nick
    [J]. DIABETES, 2022, 71
  • [8] Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis
    Haluzik, Martin
    Seufert, Jochen
    Guja, Cristian
    Bonnemaire, Mireille
    Bigot, Gregory
    Tournay, Mathilde
    Kis, Janos Tibor
    Freemantle, Nick
    [J]. DIABETES THERAPY, 2023, 14 (04) : 639 - 652
  • [9] Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis
    Martin Haluzík
    Jochen Seufert
    Cristian Guja
    Mireille Bonnemaire
    Gregory Bigot
    Mathilde Tournay
    János Tibor Kis
    Nick Freemantle
    [J]. Diabetes Therapy, 2023, 14 : 639 - 652
  • [10] Efficacy and safety of iGlarLixi vs insulin glargine 100 U/ml in Chinese people with type 2 diabetes (T2D) inadequately controlled on basal insulin (BI): LixiLan-L-China trial
    Guo, X.
    Zhang, J.
    Dong, X.
    Lu, Y.
    Pang, W.
    Gu, S.
    Ping, L.
    Nian, G.
    Niemoeller, E.
    Souhami, E.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 270 - 270
12345